High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas

NCT01148173 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: Combined systemic and intrathecal chemotherapy followed by HD-ASCT

Sponsor

Charite University, Berlin, Germany